EUVIMEDEUVIMED entdecken
Crossref

Differences in Combustible Cigarette Smoking-Related Biomarkers by Hormonal Contraceptive Use: An Exploratory Study

Alicia M Allen iD, Qing Cao, Lori G Stayer, Xianghua Luo, Joni Jensen, Raina D Pang iD, Sharon Allen, Eric C Donny iD, Neal Benowitz iD, Tracy Smith iD, Dorothy Hatsukami iD

Nicotine and Tobacco Research · 2025

DOI: 10.1093/ntr/ntaf027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Alicia M Allen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family & Community Medicine, College of Medicine - Tucson, University of Arizona, Tucson, AZ, USA. Hauptthemen laut MEDLINE: Cigarette Smoking, Contraceptive Agents, Hormonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Abuse and the Food and Drug Administration's Center for Tobacco Products, Advancing Translational Sciences, National Cancer Institute Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hormonal contraceptives (HCs), which contain synthetic forms of estrogen (ie, ethinyl estradiol) and/or progesterone (ie, progestin), are commonly used by women who smoke combustible cigarettes. Prior research has demonstrated that HCs containing ethinyl estradiol influence nicotine metabolism, though less is known about the role of progestins. We sought to examine the association between HC use and smoking-related biomarkers.

Methods

This exploratory secondary-data analysis included females, ages of 18-45, who currently smoked classified into three groups based on current HC use: (1) combination HCs (C-HC; contains ethinyl estradiol and progestin), (2) progestin-only HCs (P-HC; contains progestin only with no ethinyl estradiol), and (3) no use of hormonal contraceptives (no-HC; no current use of ethinyl estradiol nor progestins). Group differences in expired carbon monoxide, urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL), nicotine metabolite ratio (NMR), total nicotine equivalent (TNE), and the ratio of TNE to cigarettes/day were assessed.

Results

The C-HC (n = 22), P-HC (n = 67), and no-HC (n = 59) groups did not vary by age or race. Smoking-related biomarkers did not vary between the P-HC and no-HC groups. In adjusted analyses, the C-HC group had a lower TNE level (median = 41.22, interquartile range [IQR]: 32.10, 60.93) versus the P-HC group (median = 59.70, IQR = 44.89, 83.19; adjusted p-value = .006) and the no-HC group (median = 65.90, IQR = 57.55, 85.92; adjusted p-value = .010).

Conclusion

Smoking-related biomarkers were comparable between those who used progestin-only hormonal contraceptives to those who did not use any hormonal contraceptive. In contrast, TNE varied in those who used hormonal contraceptives with ethinyl estradiol. Additional research is needed to replicate these observations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cigarette SmokingContraceptive Agents, HormonalHumansFemaleBiomarkersAdultAdolescentMiddle AgedYoung AdultProgestinsEthinyl EstradiolNicotineNitrosamines

Substanzen

BiomarkersProgestinsEthinyl EstradiolNicotineContraceptive Agents, HormonalNitrosamines

Autor:innen und Institutionen

  • Department of Family & Community Medicine, College of Medicine - Tucson, University of Arizona, Tucson, AZ, USA.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA.
  • Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Department of Family Medicine & Community Health, Medical School, University of Minnesota, Minneapolis, MN, USA.
  • Department of Translational Neuroscience, Wake Forest School of Medicine, Winston-Salem, NC, USA.

ORCID-Profile: Alicia M Allen, Raina D Pang, Eric C Donny, Neal Benowitz, Tracy Smith, Dorothy Hatsukami

Förderung

  • Abuse and the Food and Drug Administration's Center for Tobacco Products
  • Advancing Translational Sciences
  • National Cancer Institute Cancer Center
  • Abuse and the Food and Drug Administration’s Center for Tobacco Products

Zitieren

APA

Allen, A. M., Cao, Q., Stayer, L. G., Luo, X., Jensen, J., Pang, R. D., Allen, S., Donny, E. C., Benowitz, N., Smith, T., & Hatsukami, D. (2025). Differences in Combustible Cigarette Smoking-Related Biomarkers by Hormonal Contraceptive Use: An Exploratory Study. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntaf027

Vancouver

Allen AM, Cao Q, Stayer LG, Luo X, Jensen J, Pang RD, et al. Differences in Combustible Cigarette Smoking-Related Biomarkers by Hormonal Contraceptive Use: An Exploratory Study. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntaf027

BibTeX
@article{Allen2025,
  author = {Allen, Alicia M and Cao, Qing and Stayer, Lori G and Luo, Xianghua and Jensen, Joni and Pang, Raina D and Allen, Sharon and Donny, Eric C and Benowitz, Neal and Smith, Tracy and Hatsukami, Dorothy},
  title = {Differences in Combustible Cigarette Smoking-Related Biomarkers by Hormonal Contraceptive Use: An Exploratory Study},
  journal = {Nicotine and Tobacco Research},
  year = {2025},
  doi = {10.1093/ntr/ntaf027}
}
Kostenlos starten →